Author response for "Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review" Article Swipe
Nasim Hafezi
,
Majid Zaki‐Dizaji
,
Matineh Nirouei
,
Gelayol Asadi
,
Niusha Sharifinejad
,
Mahnaz Jamee
,
Seyed Erfan Rasouli
,
Haleh Hamedifar
,
Araz Sabzevari
,
Zahra Chavoshzadeh
,
Reza Yazdani
,
Hassan Abolhassani
,
Asghar Aghamohammadi
,
Gholamreza Azizi
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1111/pai.13535/v2/response1
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1111/pai.13535/v2/response1
Related Topics
Concepts
Autoimmune lymphoproliferative syndrome
Medicine
Immunology
Lymphoproliferative disorders
Computational biology
Biology
Genetics
Lymphoma
Programmed cell death
Fas receptor
Apoptosis
Metadata
- Type
- peer-review
- Language
- en
- Landing Page
- https://doi.org/10.1111/pai.13535/v2/response1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3174145293
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3174145293Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1111/pai.13535/v2/response1Digital Object Identifier
- Title
-
Author response for "Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review"Work title
- Type
-
peer-reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-02-27Full publication date if available
- Authors
-
Nasim Hafezi, Majid Zaki‐Dizaji, Matineh Nirouei, Gelayol Asadi, Niusha Sharifinejad, Mahnaz Jamee, Seyed Erfan Rasouli, Haleh Hamedifar, Araz Sabzevari, Zahra Chavoshzadeh, Reza Yazdani, Hassan Abolhassani, Asghar Aghamohammadi, Gholamreza AziziList of authors in order
- Landing page
-
https://doi.org/10.1111/pai.13535/v2/response1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1111/pai.13535/v2/response1Direct OA link when available
- Concepts
-
Autoimmune lymphoproliferative syndrome, Medicine, Immunology, Lymphoproliferative disorders, Computational biology, Biology, Genetics, Lymphoma, Programmed cell death, Fas receptor, ApoptosisTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3174145293 |
|---|---|
| doi | https://doi.org/10.1111/pai.13535/v2/response1 |
| ids.doi | https://doi.org/10.1111/pai.13535/v2/response1 |
| ids.mag | 3174145293 |
| ids.openalex | https://openalex.org/W3174145293 |
| fwci | |
| type | peer-review |
| title | Author response for "Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review" |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10685 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9944000244140625 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Viral-associated cancers and disorders |
| topics[1].id | https://openalex.org/T10185 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9936000108718872 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2734 |
| topics[1].subfield.display_name | Pathology and Forensic Medicine |
| topics[1].display_name | Lymphoma Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T11020 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9858999848365784 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Immune Cell Function and Interaction |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778959938 |
| concepts[0].level | 5 |
| concepts[0].score | 0.5557305216789246 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1151300 |
| concepts[0].display_name | Autoimmune lymphoproliferative syndrome |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.5468270182609558 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C203014093 |
| concepts[2].level | 1 |
| concepts[2].score | 0.45692822337150574 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[2].display_name | Immunology |
| concepts[3].id | https://openalex.org/C2776995267 |
| concepts[3].level | 3 |
| concepts[3].score | 0.41991671919822693 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q4165484 |
| concepts[3].display_name | Lymphoproliferative disorders |
| concepts[4].id | https://openalex.org/C70721500 |
| concepts[4].level | 1 |
| concepts[4].score | 0.3519951105117798 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[4].display_name | Computational biology |
| concepts[5].id | https://openalex.org/C86803240 |
| concepts[5].level | 0 |
| concepts[5].score | 0.22741052508354187 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[5].display_name | Biology |
| concepts[6].id | https://openalex.org/C54355233 |
| concepts[6].level | 1 |
| concepts[6].score | 0.22161000967025757 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[6].display_name | Genetics |
| concepts[7].id | https://openalex.org/C2779338263 |
| concepts[7].level | 2 |
| concepts[7].score | 0.05632394552230835 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q208414 |
| concepts[7].display_name | Lymphoma |
| concepts[8].id | https://openalex.org/C31573885 |
| concepts[8].level | 3 |
| concepts[8].score | 0.0 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q304484 |
| concepts[8].display_name | Programmed cell death |
| concepts[9].id | https://openalex.org/C3031857 |
| concepts[9].level | 4 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1649375 |
| concepts[9].display_name | Fas receptor |
| concepts[10].id | https://openalex.org/C190283241 |
| concepts[10].level | 2 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q14599311 |
| concepts[10].display_name | Apoptosis |
| keywords[0].id | https://openalex.org/keywords/autoimmune-lymphoproliferative-syndrome |
| keywords[0].score | 0.5557305216789246 |
| keywords[0].display_name | Autoimmune lymphoproliferative syndrome |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.5468270182609558 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/immunology |
| keywords[2].score | 0.45692822337150574 |
| keywords[2].display_name | Immunology |
| keywords[3].id | https://openalex.org/keywords/lymphoproliferative-disorders |
| keywords[3].score | 0.41991671919822693 |
| keywords[3].display_name | Lymphoproliferative disorders |
| keywords[4].id | https://openalex.org/keywords/computational-biology |
| keywords[4].score | 0.3519951105117798 |
| keywords[4].display_name | Computational biology |
| keywords[5].id | https://openalex.org/keywords/biology |
| keywords[5].score | 0.22741052508354187 |
| keywords[5].display_name | Biology |
| keywords[6].id | https://openalex.org/keywords/genetics |
| keywords[6].score | 0.22161000967025757 |
| keywords[6].display_name | Genetics |
| keywords[7].id | https://openalex.org/keywords/lymphoma |
| keywords[7].score | 0.05632394552230835 |
| keywords[7].display_name | Lymphoma |
| language | en |
| locations[0].id | doi:10.1111/pai.13535/v2/response1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | peer-review |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1111/pai.13535/v2/response1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5071197619 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-3666-1620 |
| authorships[0].author.display_name | Nasim Hafezi |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | None Hafezi, Nasim |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5074794822 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-1642-3289 |
| authorships[1].author.display_name | Majid Zaki‐Dizaji |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | None Zaki-Dizaji, Majid |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5014486732 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-7092-4239 |
| authorships[2].author.display_name | Matineh Nirouei |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | None Nirouei, Matineh |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5078550889 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-7197-541X |
| authorships[3].author.display_name | Gelayol Asadi |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | None Asadi, Gelayol |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5002799085 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-5675-1001 |
| authorships[4].author.display_name | Niusha Sharifinejad |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | None Sharifinejad, Niusha |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5014613344 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-0732-9170 |
| authorships[5].author.display_name | Mahnaz Jamee |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | None Jamee, Mahnaz |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5090636400 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-6906-5839 |
| authorships[6].author.display_name | Seyed Erfan Rasouli |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | None Erfan Rasouli, Seyed |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5024536677 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2308-8925 |
| authorships[7].author.display_name | Haleh Hamedifar |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | None Hamedifar, Haleh |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5045786342 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Araz Sabzevari |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | None Sabzevari, Araz |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5087698983 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-1869-8630 |
| authorships[9].author.display_name | Zahra Chavoshzadeh |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | None Chavoshzadeh, Zahra |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5025067610 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Reza Yazdani |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | None Yazdani, Reza |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5051258190 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-4838-0407 |
| authorships[11].author.display_name | Hassan Abolhassani |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | None Abolhassani, Hassan |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5040499257 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-9454-1603 |
| authorships[12].author.display_name | Asghar Aghamohammadi |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | None Aghamohammadi, Asghar |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5057262090 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-5658-2511 |
| authorships[13].author.display_name | Gholamreza Azizi |
| authorships[13].author_position | last |
| authorships[13].raw_author_name | None Azizi, Gholamreza |
| authorships[13].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1111/pai.13535/v2/response1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Author response for "Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review" |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10685 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9944000244140625 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Viral-associated cancers and disorders |
| related_works | https://openalex.org/W3155805112, https://openalex.org/W2131980017, https://openalex.org/W2253670074, https://openalex.org/W4239447275, https://openalex.org/W2342022671, https://openalex.org/W4253888283, https://openalex.org/W2041482161, https://openalex.org/W2015835486, https://openalex.org/W3123599973, https://openalex.org/W2325796893 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1111/pai.13535/v2/response1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | peer-review |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1111/pai.13535/v2/response1 |
| primary_location.id | doi:10.1111/pai.13535/v2/response1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | peer-review |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1111/pai.13535/v2/response1 |
| publication_date | 2021-02-27 |
| publication_year | 2021 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 14 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.4099999964237213 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile |